Index · Artikel · Tanning beds raise risk of common skin cancer: study

Tanning beds raise risk of common skin cancer: study

2011-12-13 4
   
Advertisement
résumén">Tanning beds have already been linked to an increased risk of the deadliest type of skin cancer and now new research shows they can also raise the odds of developing the most common form of the disease. Scientists at the Yale School of Public H
Advertisement

Tanning beds raise risk of common skin cancer: study


n">Tanning beds have already been linked to an increased risk of the deadliest type of skin cancer and now new research shows they can also raise the odds of developing the most common form of the disease.

Scientists at the Yale School of Public Health in New Haven, Connecticut found that young people who tanned on the indoor beds had a 69 percent increased chance of suffering from early-onset basal cell carcinoma (BCC).

"Indoor tanning was strikingly common in our study of young skin cancer patients, especially in the women, which may partially explain why 70 percent of early-onset BCCs are in females," Susan T. Mayne, the senior author of the study and a professor at the School of Public Health, said in a statement.

The findings, which are reported in the Journal of the American Academy of Dermatology, support earlier research from the University of Minnesota, where scientists discovered that people who used tanning beds, regardless of the type or for how long, were 74 percent more likely to develop melanoma, the most serious form of skin cancer.

Mayne and her colleagues interviewed 750 people younger than 40 years old. They analyzed the type of tanning beds used, for how long and how often, any burns that resulted and the age when the beds were first used.

They noted that the risks increased with the number of years the tanning beds had been used.

"We were also surprised to find that one-third of our study participants with BCC had already had at least one additional BCC before age 40, which is very alarming as skin cancers increase in frequency in age," Mayne added.

About 30 million people in the United State use indoor tanning beds, which the World Health Organization classifies as a human carcinogen. In the United States tanning beds are considered a medical device.

Medical experts in the United States have called for stronger regulations on the use of tanning beds.

Cases of melanoma have been rising for the past three decades. Although it only accounts for about for five percent of skin cancer cases it causes the majority of death from the disease. About 70,230 new cases will be diagnosed this year, according to the American Cancer Society.

Cases of basal cell cancers are also on the rise but they are likely to be cured if detected and treated early.

"Importantly, indoor tanning is a behavior that individuals can change," said Leah M. Ferrucci, a postdoctoral fellow at the Yale School of Public Health and a co-author of the research.

"In conjunction with the findings on melanoma, our results for BCC indicate that reducing indoor tanning could translate to a meaningful reduction in the incidence of these two types of skin cancer," she added.

  • Tanning beds raise risk of common skin cancer: study

    Tanning beds raise risk of common skin cancer: study
    n">Tanning beds have already been linked to an increased risk of the deadliest type of skin cancer and now new research shows they can also raise the odds of developing the most common form of the disease. Scientists at the Yale School of Public H
    2011-12-13 CANCERTANNINGBEDS
  • Common skin cancer drug smoothes wrinkles: study

    Common skin cancer drug smoothes wrinkles: study
    CHICAGO A cream used to treat the early signs of skin cancer may erase wrinkles and leave behind younger-looking skin, U.S. researchers said on Monday. They said Valeant Pharmaceuticals' cream Efudex, which is used to treat actinic keratoses, a preca
    2009-06-16 CANCERSKIN
  • Some tanners return to the booth after skin cancer

    Some tanners return to the booth after skin cancer
    NEW YORK (Reuters Health) - One in seven people goes back to a tanning bed after being diagnosed with skin cancer, according to a new research letter. Indoor tanning is known to increase a person's risk for cancer. "The situation may be analogous to
  • Roche gets Swiss approval for skin cancer drug

    Roche gets Swiss approval for skin cancer drug
    ZURICH Swiss drugmaker Roche Holding AG has received Swiss approval for Erivedge, the first medicine for people with advanced forms of basal cell carcinoma, the most common skin cancer. Roche, the world's largest maker of cancer drugs, said about 10,
    2013-06-11 ROCHECARCINOMA
  • German Merck, Pfizer immunotherapy shows promise in rare skin cancer

    German Merck, Pfizer immunotherapy shows promise in rare skin cancer
    n">Germany's Merck KGaA (MRCG.DE) on Wednesday reported encouraging interim data against a rare and aggressive form of skin cancer from a mid-stage trial of its experimental drug that helps the immune system attack tumors. In the 61-patient study,
    2016-05-18 CANCERHEALTHMERCK
  • Could mobile devices raise skin cancer risk?

    Could mobile devices raise skin cancer risk?
    n">(Reuters Health) - Devices like tablets, smartphones and laptops can reflect ultraviolet light from the sun and may indirectly increase users' exposure to the cancer-causing wavelengths, according to a new study. "These devices are general
  • Tanning may up skin cancer risk for palest kids

    Tanning may up skin cancer risk for palest kids
    NEW YORK (Reuters Health) - Very light-skinned children who tan in the sun develop significantly more moles than their peers who stay pale in the sun, new research shows. The number of moles a person has is among the strongest risk factors for develo
    2009-09-22 CANCERTANNING
  • Tanning beds raise melanoma risk, U.S. study finds

    Tanning beds raise melanoma risk, U.S. study finds
    CHICAGO Indoor tanning beds sharply increase the risk of melanoma, the deadliest kind of skin cancer, and the risk increases over time, U.S. researchers said on Thursday, and others experts called for tighter regulation. They said people who use any
    2010-05-27 CANCERSKINTANNING
  • Tanning beds must carry skin cancer warning: U.S. FDA

    Tanning beds must carry skin cancer warning: U.S. FDA
    n">The U.S. Food and Drug Administration is strengthening its regulation of tanning beds, which have been shown to increase the risk of skin cancer. The FDA, which is reclassifying sun lamp products from low risk to moderate risk, said on Thursday
    2014-05-29 FDATANNING
  • Should your hairdresser screen you for skin cancer?

    Should your hairdresser screen you for skin cancer?
    NEW YORK (Reuters Health) - Next time you get a haircut, you might end up with something you didn't expect: a referral to a dermatologist. A survey of Texas hair salons out today found more than a third of stylists check at least half of their custom
    2011-10-17 HAIRDRESSER
  • FDA approves Roche skin cancer drug

    FDA approves Roche skin cancer drug
    n">U.S. health regulators on Monday approved Roche's pill to treat an advanced form of the most common form of skin cancer, known as basal cell carcinoma. The drug, Erivedge, which was co-developed by Curis Inc, was given a green light by the Food
    2012-01-30 ROCHEAPPROVAL
  • FDA approves Novartis's advanced skin cancer drug

    FDA approves Novartis's advanced skin cancer drug
    n">The U.S. Food and Drug Administration approved Novartis AG's oral pill to treat the most common form of advanced skin cancer. The drug, Odomzo, carry a boxed warning to alert the risks that it may cause death or severe birth defects in a develo
    2015-07-24 FDANOVARTIS
  • Skin cancer more deadly when caught during pregnancy

    Skin cancer more deadly when caught during pregnancy
    n">(Reuters Health) - Melanoma may be even more dangerous when it's diagnosed in women during pregnancy or within a year of giving birth, a U.S. study suggests. Among women under 50 with malignant melanoma, those diagnosed during or soon after pre
  • Skin cancer can be inherited: studies

    Skin cancer can be inherited: studies
    NEW YORK (Reuters Health) - Want to reduce your risk of skin cancer? Wear sun screen, of course. But two new studies suggest that choosing your relatives carefully could also be helpful. One found that having an identical twin with melanoma increased
    2009-10-10 CANCERSKIN
  • Positive skin cancer drug data boosts Roche

    Positive skin cancer drug data boosts Roche
    ZURICH Roche's new cancer drug vismodegib could help patients with a potentially fatal skin cancer type, positive mid-stage trial results showed, going some way to lift confidence in the drugmaker after a rough 2010. Roche is struggling to find its f
    2011-03-21 ROCHE
  • Panel backs skin cancer advice for youths

    Panel backs skin cancer advice for youths
    NEW YORK (Reuters Health) - A government-backed expert panel joined in the fight against skin cancer on Tuesday with a proposal urging doctors to counsel fair-skinned youths about sun protection. "The definition of fair skin is it doesn't tan very we
    2011-11-08 CANCER
  • FDA panel recommends approval for Amgen's skin cancer immunotherapy

    FDA panel recommends approval for Amgen's skin cancer immunotherapy
    n">Amgen Inc's skin cancer immunotherapy showed enough efficacy in the treatment of melanoma to be given marketing approval, an independent advisory panel to the U.S. Food and Drug Administration said on Wednesday. The panel voted 22-1 supporting
    2015-04-29 FDAAmgen
  • Novartis study shows skin cancer combo also works on lungs

    Novartis study shows skin cancer combo also works on lungs
    n">A Novartis trial of two drugs against an aggressive lung cancer bodes well for broadening their use beyond melanoma, the Swiss drugmaker told the American Society of Clinical Oncology's conference in Chicago on Monday. Novartis's Tafinlar and M
  • Studies show how skin cancer evades promising drug

    Studies show how skin cancer evades promising drug
    CHICAGO U.S. researchers have uncovered several ways in which melanoma can outsmart a promising experimental cancer pill called PLX4032, a finding that could lead to new drugs to keep the deadly skin cancer at bay, the teams said on Wednesday. Resear
    2010-11-24 CANCERPILLRELAPSE
  • FDA approves Roche skin cancer drug Zelboraf

    FDA approves Roche skin cancer drug Zelboraf
    WASHINGTON U.S. drug regulators on Wednesday approved a targeted skin cancer drug from Roche Holding along with its diagnostic test, an advance in personalized health care. The Food and Drug Administration was two months ahead of schedule in approvin
    2011-08-17 ROCHEZELBORAF

TOP

  • Day/
  • Week/
  • Original/
  • Recommand

Updated